Publications by authors named "Ian Hunneyball"

Claim this Profile
T
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Michael R Paillasse, Michael Esquerré, Florie A Bertrand, Céline Poussereau-Pomié, Mélanie Pichery, Ian Hunneyball

Cancer Res Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch.
Ivan Berlin, Ian M Hunneyball, Doris Greiling, Stephen P Jones, Hermann Fuder

Psychopharmacology (Berl)· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
James K Walsh, Lynette Salkeld, Lisa J Knowles, Tim Tasker, Ian M Hunneyball

Sleep Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
James K Walsh, Steve Thacker, Lisa J Knowles, Tim Tasker, Ian M Hunneyball

Sleep Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharma-entomology: when bugs become drugs.
Jean Luc Dimarcq, Ian Hunneyball

Drug Discov Today· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis